4.2 Article

Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma

Yongqiang Wei et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)

Article Clinical Neurology

Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy

Daniel B. Rubin et al.

JAMA NEUROLOGY (2020)

Article Hematology

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

Daniel W. Lee et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Review Cell Biology

Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspective

Hamid Reza Mirzaei et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Hematology

An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer

Steven Feins et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Article Medicine, General & Internal

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

S. S. Neelapu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients

Amit Akirov et al.

AMERICAN JOURNAL OF MEDICINE (2017)

Article Hematology

Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes

Rami S. Komrokji et al.

AMERICAN JOURNAL OF HEMATOLOGY (2012)